Literature DB >> 2339096

Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.

A Hoffman1, G Levy.   

Abstract

The central nervous system (CNS) sensitivity to the hypnotic (general anesthetic) action of phenobarbital and to the neurotoxic (convulsive) action of theophylline is greater in rats with acute renal failure than in normal animals, consistent with clinical observations. In the case of phenobarbital, this increased sensitivity can be produced in normal rats by infusion of a solution of the lyophilized dialysate of serum from rats with renal failure. It was hypothesized that the relevant constituent(s) of this dialysate may circulate between the blood and the intestinal lumen and that it (they) can be adsorbed by orally administered activated charcoal and thereby removed from the body. If so, treatment of renal failure rats with activated charcoal should partly reverse the increased CNS sensitivity to phenobarbital and to other drugs similarly affected. Accordingly, rats with renal failure produced by bilateral ligation of ureters were given an aqueous suspension of activated charcoal, about 1 g per kg body weight, orally every 8 hr for six doses. Uremic controls received equal volumes of water. About 2 hr after the last dose, the animals were infused i.v. with phenobarbital to onset of loss of righting reflex or with theophylline to onset of maximal seizures. In the phenobarbital study, charcoal treatment partly reversed the hypothermia associated with renal failure and caused a reduction of creatinine and total bilirubin concentrations in serum. The cerebrospinal fluid (CSF) concentration of phenobarbital at onset of loss of the righting reflex was significantly higher in charcoal treated rats than in their controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339096     DOI: 10.1023/a:1015865810667

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  CHRONIC INTRAVENOUS CANNULAS FOR RATS.

Authors:  J R WEEKS; J D DAVIS
Journal:  J Appl Physiol       Date:  1964-05       Impact factor: 3.531

2.  Effect of small variations in heat stimulus temperature on the tail flick response of rats in analgesimetry.

Authors:  J JUSZKIEWICZ-DONSBACH; G LEVY
Journal:  J Pharm Sci       Date:  1962-02       Impact factor: 3.534

3.  Sorbents in the management of uremia.

Authors:  E A Friedman
Journal:  Am J Med       Date:  1976-05-10       Impact factor: 4.965

4.  Systemic effect of ipecac on acute toxicity of phenobarbital and theophylline in rats.

Authors:  S Sato; G Levy
Journal:  Fundam Appl Toxicol       Date:  1989-10

5.  Kinetics of drug action in disease states. XIII. Effect of dialyzable component(s) of uremic blood on phenobarbital concentrations in rats at onset of loss of righting reflex.

Authors:  M Hisaoka; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

6.  Effect of experimental azotemia on intestinal transport of butyric acid.

Authors:  N D Vaziri; A Barbari; D Hollander; T Vincent; L Tran; F Oveisi; M V Pahl; L Bissar
Journal:  Proc Soc Exp Biol Med       Date:  1989-02

7.  Oral activated charcoal to enhance theophylline elimination in an acute overdose.

Authors:  P Gal; A Miller; J D McCue
Journal:  JAMA       Date:  1984-06-15       Impact factor: 56.272

8.  Increased serum theophylline clearance with orally administered activated charcoal.

Authors:  C K Mahutte; R J True; T M Michiels; J M Berman; R W Light
Journal:  Am Rev Respir Dis       Date:  1983-11

9.  Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.

Authors:  R C Chou; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

10.  Binding of hippurate in normal plasma and in uremic plasma pre- and postdialysis.

Authors:  P C Farrell; F A Gotch; J H Peters; B J Berridge; M Lam
Journal:  Nephron       Date:  1978       Impact factor: 2.847

View more
  3 in total

1.  Effect of acute renal failure on neurotoxicity of cimetidine in rats.

Authors:  Y Nakada; K Yamamoto; J Kawakami; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

2.  Effect of experimental renal failure and hypotonic hyponatremia on the pharmacodynamics of cefazolin-induced seizures in rats.

Authors:  Masashi Nagata; Takuya Fujichika; Masato Yasuhara
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

3.  Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models.

Authors:  Meindert Danhof
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-30       Impact factor: 2.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.